Phase 1 evaluation of an elastomeric nucleus pulposus device as an option to augment disc at microdiscectomy: Experimental results from biomechanical and biocompatibility testing and first in human

Author:

Chen Xiaolong12ORCID,Kohan Saeed3,Bhargav Divya2,Choi Johnathon2,Perera Senori2,Dean Cameron2,Chopra Neha14,Sial Alisha14,Sandhu Harvinder S.5,Apos Esther26,Appleyard Richard7,Diwan Ashish D.14

Affiliation:

1. Spine Labs, St. George & Sutherland Clinical School, University of New South Wales Sydney New South Wales Australia

2. Kunovus Technologies Sydney New South Wales Australia

3. St. George Hospital, University of New South Wales Sydney New South Wales Australia

4. Spine Service, Department of Orthopaedic Surgery St. George Hospital Campus Sydney New South Wales Australia

5. Spinal Surgical Service, Hospital for Special Surgery, Weill Medical College of Cornell University New York New York USA

6. Cmsscidoc Pty Ltd Melbourne Victoria Australia

7. Orthopaedic Biomechanics Research Group, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences Macquarie University Sydney New South Wales Australia

Abstract

AbstractObjectiveWhilst microdiscectomy is an excellent reliever of pain for recalcitrant lumbar disc herniation (LDH), it has a high failure rate over time due to the ensuing reduction in mechanical stabilization and support of the spine. One option is to clear the disc and replace it with a nonhygroscopic elastomer. Here, we present the evaluation of biomechanical and biological behavior of a novel elastomeric nucleus device (Kunovus disc device [KDD]), consisting of a silicone jacket and a two‐part in situ curing silicone polymer filler.Materials and MethodsISO 10993 and American Society for Testing and Materials (ASTM) standards were used to evaluate the biocompatibility and mechanics of KDD. Sensitization, intracutaneous reactivity, acute systemic toxicity, genotoxicity, muscle implantation study, direct contact matrix toxicity assay, and cell growth inhibition assay were performed. Fatigue test, static compression creep testing, expulsion testing, swell testing, shock testing, and aged fatigue testing were conducted to characterize the mechanical and wear behavior of the device. Cadaveric studies to develop a surgical manual and evaluate feasibility were conducted. Finally, a first‐in‐human implantation was conducted to complete the proof of principle.ResultsThe KDD demonstrated exceptional biocompatibility and biodurability. Mechanical tests showed no Barium‐containing particles in fatigue test, no fracture of nucleus in static compression creep testing, no extrusion and swelling, and no material failure in shock and aged fatigue testing. Cadaver training sessions showed that KDD was deemed implantable during microdiscectomy procedures in a minimally invasive manner. Following IRB approval, the first implantation in a human showed no intraoperative vascular and neurological complications and demonstrated feasibility. This successfully completed Phase 1 development of the device.ConclusionThe elastomeric nucleus device may mimic native disc behavior in mechanical tests, offering an effective way for treating LDH by way of Phase 2 and subsequent clinical trials or postmarket surveillance in the future.

Publisher

Wiley

Subject

Orthopedics and Sports Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3